Quantel Medical Launches C.STIM, a New Generation IPL System for Dry Eye

Quantel Medical announced the launch of C.STIM IPL system. Based on intense pulsed light technology, C.STIM is the new generation of IPL designed to treat the root causes of dry eyes: meibomian gland dysfunction, inflammation, and demodex.

“Thanks to the unique Stim-ULI technology (Uniform Light Intensity), C.STIM offers the best combination of clinical efficacy and patient comfort," Delphine Southon, Dry Eye Product Manager, Quantel Medical, said in a company news release.

C.STIM has been designed with the aim of combining cutting-edge technology with a sleek, robust and ergonomic design. The device integrates technological features to guarantee efficacy, safety, and ergonomics, and to offer a “plug and play” product easy delegable.

“Drawing on Quantel Medical years of experience in intense pulsed light in dermatology, we have now developed a new IPL device exclusively for use in ophthalmology, designed and manufactured by the Lumibird Medical group," said Jean-Marc Gendre, CEO of Lumibird Medical. "We are convinced that this new premium product of our dry eye range will bring an innovative therapeutic solution to ophthalmologists confronted with the daily challenge of dry eye treatment.”

Delegates attending The 52ndRoyal Australian and New Zealand College of Ophthalmologists (RANZCO) Virtual Meeting February 26–March 1 will have the opportunity to discover the C.STIM IPL System on the Ellex | Quantel Medical - Lumibird Medical virtual booth.